← SynDRA
DASOTRALINE
SynDRA canonical compound SYN0038026 — structure-anchored drug synonym record
| Clinical phase | Phase 3 |
|---|
| Primary target(s) | DRD2 | HTR1A | SLC6A2 | SLC6A3 | SLC6A4 |
|---|
| Mechanism of action | dopamine-norepinephrine-serotonin reuptake inhibitor |
|---|
All known targets
- SLC6A2
- SLC6A3
- SLC6A4
- DRD2
- HTR1A
Mechanisms of action (all sources)
- SLC6A4 INHIBITOR
- Monoamine transporter inhibitor
- SLC6A3 INHIBITOR
- SLC6A2 INHIBITOR
- dopamine-norepinephrine-serotonin reuptake inhibitor
Cross-references
Synonyms
- Dasotralina
- (1r,4s)-trans-norsertraline
- Norsertraline, (1r,4s)-trans-
- SEP-225289
- SEP-289
- Triple reuptake inhibitors (depression), Sepracor
- (1R,4S)-trans-Norsertraline
- Norsertraline, (1R,4S)-trans-
- Dasotraline [USAN:INN]
- 4D28EY0L5T
- DASOTRALINE [INN]
- DASOTRALINE [USAN]
- DASOTRALINE [WHO-DD]
- SEP-225,289
- dasotralinum
- RefChem:585202
- DTXCID70140346
- C16H15Cl2N
- UNII-4D28EY0L5T
- Sertraline Impurity 37
- Dasotraline (USAN/INN)
- SCHEMBL263142
- Dasotraline; SEP 225289
- GTPL8308
- SCHEMBL29690290
- EX-A2622
- Dasotraline(SEP-225289) free base?
- AC-36184
- DA-72569
- HY-12850
- CS-0012724
- NS00069019
- D10700
- T60607
- (1R,4S)-4-(3,4-dichlorophenyl)tetralin-1-amine
- (1R,4S)-trans-norsertraline
- SEP225289
- ダソトラリン
Look up DASOTRALINE in the interactive SynDRA portal →